Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
PLoS Negl Trop Dis ; 11(12): e0006105, 2017 12.
Artículo en Inglés | MEDLINE | ID: mdl-29267276

RESUMEN

BACKGROUND: Knowledge of infectious disease burden is necessary to appropriately allocate resources for prevention and control. In Latin America, rabies is among the most important zoonoses for human health and agriculture, but the burden of disease attributed to its main reservoir, the common vampire bat (Desmodus rotundus), remains uncertain. METHODOLOGY/PRINCIPAL FINDINGS: We used questionnaires to quantify under-reporting of livestock deaths across 40 agricultural communities with differing access to health resources and epidemiological histories of vampire bat rabies (VBR) in the regions of Apurimac, Ayacucho and Cusco in southern Peru. Farmers who believed VBR was absent from their communities were one third as likely to report livestock deaths from disease as those who believed VBR was present, and under-reporting increased with distance from reporting offices. Using generalized mixed-effect models that captured spatial autocorrelation in reporting, we project 4.6 (95% CI: 4.4-8.2) rabies cases per reported case and identify geographic areas with potentially greater VBR burden than indicated by official reports. Spatially-corrected models estimate 505-724 cattle deaths from VBR in our study area during 2014 (421-444 deaths/100,000 cattle), costing US$121,797-171,992. Cost benefit analysis favoured vaccinating all cattle over the current practice of partial vaccination or halting vaccination all together. CONCLUSIONS: Our study represents the first estimate of the burden of VBR in Latin America to incorporate data on reporting rates. We confirm the long-suspected cost of VBR to small-scale farmers and show that vaccinating livestock is a cost-effective solution to mitigate the burden of VBR. More generally, results highlight that ignoring geographic variation in access to health resources can bias estimates of disease burden and risk.


Asunto(s)
Enfermedades de los Bovinos/economía , Quirópteros/virología , Costo de Enfermedad , Rabia/veterinaria , Animales , Bovinos , Enfermedades de los Bovinos/prevención & control , Análisis Costo-Beneficio , Perú , Rabia/economía , Rabia/prevención & control , Vacunación/veterinaria
2.
Am J Trop Med Hyg ; 96(6): 1307-1317, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28719253

RESUMEN

AbstractHaiti has the highest burden of rabies in the Western hemisphere, with 130 estimated annual deaths. We present the cost-effectiveness evaluation of an integrated bite case management program combining community bite investigations and passive animal rabies surveillance, using a governmental perspective. The Haiti Animal Rabies Surveillance Program (HARSP) was first implemented in three communes of the West Department, Haiti. Our evaluation encompassed all individuals exposed to rabies in the study area (N = 2,289) in 2014-2015. Costs (2014 U.S. dollars) included diagnostic laboratory development, training of surveillance officers, operational costs, and postexposure prophylaxis (PEP). We used estimated deaths averted and years of life gained (YLG) from prevented rabies as health outcomes. HARSP had higher overall costs (range: $39,568-$80,290) than the no-bite-case-management (NBCM) scenario ($15,988-$26,976), partly from an increased number of bite victims receiving PEP. But HARSP had better health outcomes than NBCM, with estimated 11 additional annual averted deaths in 2014 and nine in 2015, and 654 additional YLG in 2014 and 535 in 2015. Overall, HARSP was more cost-effective (US$ per death averted) than NBCM (2014, HARSP: $2,891-$4,735, NBCM: $5,980-$8,453; 2015, HARSP: $3,534-$7,171, NBCM: $7,298-$12,284). HARSP offers an effective human rabies prevention solution for countries transitioning from reactive to preventive strategies, such as comprehensive dog vaccination.


Asunto(s)
Mordeduras y Picaduras/economía , Mordeduras y Picaduras/epidemiología , Manejo de Caso/economía , Rabia/economía , Rabia/epidemiología , Rabia/prevención & control , Animales , Análisis Costo-Beneficio , Enfermedades de los Perros/epidemiología , Enfermedades de los Perros/prevención & control , Perros , Haití/epidemiología , Humanos , Profilaxis Posexposición/economía , Vacunas Antirrábicas/administración & dosificación , Vacunas Antirrábicas/economía , Vacunación
3.
Transbound Emerg Dis ; 61(2): 140-6, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22984914

RESUMEN

Vampire bat rabies causes significant impacts within its endemic range in Mexico. These impacts include livestock mortality, animal testing costs, post-exposure prophylaxis costs, and human mortality risk. Mitigation of the impacts can be achieved by vaccinating livestock and controlling vampire bat populations. A benefit-cost analysis was performed to examine the economic efficiency of these methods of mitigation, and Monte Carlo simulations were used to examine the impact that uncertainty has on the analysis. We found that livestock vaccination is efficient, with benefits being over six times higher than costs. However, bat control is inefficient because benefits are very unlikely to exceed costs. It is concluded that when these mitigation methods are judged by the metric of economic efficiency, livestock vaccination is desirable but bat control is not.


Asunto(s)
Enfermedades de los Bovinos/economía , Quirópteros/virología , Brotes de Enfermedades/economía , Vacunas Antirrábicas/economía , Virus de la Rabia/inmunología , Rabia/veterinaria , Vacunación/veterinaria , Animales , Bovinos , Enfermedades de los Bovinos/prevención & control , Enfermedades de los Bovinos/virología , Análisis Costo-Beneficio , Brotes de Enfermedades/prevención & control , Brotes de Enfermedades/veterinaria , Reservorios de Enfermedades/veterinaria , Reservorios de Enfermedades/virología , México/epidemiología , Rabia/economía , Rabia/prevención & control , Rabia/virología , Vacunas Antirrábicas/administración & dosificación , Vacunación/economía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA